Salesforce.com to B...
Health Care: Health Services
CAS Medical Systems Inc. (CASM: NASDAQ)
$1.92 0.00 | 0.00%
06/04/12 - 09:30 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.92 |
| 52 Week High | 3.05 |
| 52 Week Low | 1.50 |
| Avg. Daily Vol. (Mil) | 0.01 |
| Beta (3 year) | 0.38 |
| Share Related Items | |
| Mkt Cap (Mil) | 26.15 |
| Shares Out (Mil) | 13.62 |
| Float (Mil) | 3.84 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.00 |
| Current Ratio | 6.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.18 |
| Price/Book | 7.65 |
| Price/Cash Flow | -3.80 |
| Per Share Data | |
| Earnings | -0.59 |
| Sales | 1.63 |
| Book Value | 0.25 |
| Cash Flow | -0.50 |
| Business Summary | |
|---|---|
| CAS Medical Systems, Inc. is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that are vital to patient care. | |
| General Information | |
| 44 East Industrial Road
Branford, CT 06405 |
|
| www.casmed.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 107 | |
| CEO: Thomas M. Patton | |
| Short Interest | |
| Current Month (Mil) | 0.01 |
| Previous Month (Mil) | 0.01 |
| Short Interest Ratio (Days) | 0.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -32.20 |
| Return on Investments | -39.00 |
| Profitability | |
| Gross Margin | 42.10 |
| EBIT Margin | -32.00 |
| Profit Margin | -30.70 |
Portfolios with CASM
- Portfolio NameUser Type
- UserAshley
- ContributorUnder-$10 Setting Up To Tra...
- Contributor26 Small-Cap Stocks in Dang...
- Contributor8 Health Care Penny Stocks ...
- Usermsi Portfolio 1
- UserJane's SEP
- Userleon16066 Portfolio 1
- UserAdam Portfolio 1
Latest CASM Headlines from TheStreet
- 5 Stocks Under $10 Poised to Move Higher 04.05.12 | 01:04 pm
- CASMED Reports Fourth Quarter And Full Year 2010 Results 03.02.11 | 08:03 am
- CASMED Announces Fourth Quarter And Year-End 2010 Earnings Release Date And Conference Call Information 02.23.11 | 08:02 am
- CASMED Receives FDA Clearance For Non-Cerebral Indication Of FORE-SIGHT Absolute Tissue Oximeter 01.18.11 | 08:01 am
- CASMED Reports Inducement Grants To VP Of Sales And Marketing Matthew J. Herwig Under NASDAQ Marketplace Rule 5635 01.10.11 | 10:01 am
- CASMED Announces Key Addition To Executive Management Team 01.10.11 | 08:01 am
- CASMED Reports Third Quarter 2010 Results 11.10.10 | 04:11 pm
- CASMED Announces Third Quarter 2010 Earnings Release Date And Conference Call Information 11.03.10 | 08:11 am
- Gregory Rainey Appointed To CASMED Board 11.01.10 | 03:11 pm
- CASMED Announces 9 Scientific Abstracts Demonstrating The Benefits Of FORE-SIGHT Absolute Oximetry 10.21.10 | 08:10 am
Press Releases for CASM
Partner Headlines for CASM
- CASMED Reports Third Quarter EPS of $(0.04) - Benzinga 11.10.10 | 04:11 pm
- UPDATE 1-CAS Medical gets new Japanese patent, shares jump - Reuters 04.13.10 | 10:04 am
